This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Food and Drug Administration approval of the FARAPULSE PFA System in the first quarter of 2024. Circulation. Additional information about clinical evidence supporting the device can be found here. Caution: Investigational Device. Limited by Federal (or US) law to investigational use only. Not available for sale.
milla1cf Fri, 02/02/2024 - 17:02 February 2, 2024 — Biosense Webster, Inc. , Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Circulation Research. Int J Stroke.
Circulation, Volume 150, Issue Suppl_1 , Page A4141066-A4141066, November 12, 2024. Background:Clinical studies on atrialfibrillation (AF) recurrence after catheter ablation in patients diagnosed with patent foramen ovale (PFO) and paroxysmal AF (PAF) are scarce.
Circulation, Volume 150, Issue Suppl_1 , Page A4139226-A4139226, November 12, 2024. Background:Anticoagulation is the standard treatment for the majority of patients with atrialfibrillation (AF) to reduce the risk of stroke. Such patients are at high risk for bleeding and stroke.
Circulation, Volume 150, Issue Suppl_1 , Page A4135095-A4135095, November 12, 2024. Background:While anticoagulation is crucial for atrialfibrillation (AF) patients to prevent ischemic events, those with thrombocytopenia have a potential increased risk of bleeding.
Circulation, Volume 150, Issue Suppl_1 , Page A4137488-A4137488, November 12, 2024. Background:It is desirable to improve rhythm control management of atrialfibrillation (AF). Extracellular potassium ([K+]0) may affect AF generation and anti-AF efficacy of the sodium channel blockers.Methods:AF burden (i.e.,
Circulation, Volume 150, Issue Suppl_1 , Page A4145826-A4145826, November 12, 2024. specificity.Conclusion:In this retrospective analysis, classification of the dynamic system model singular values identified patients at high risk for atrialfibrillation from sinus rhythm period. 17.64), yielding 72.9%
Circulation, Volume 150, Issue Suppl_1 , Page A4139970-A4139970, November 12, 2024. Introduction:Anticoagulation (AC) is the mainstay of thromboprophylaxis for stroke prevention in atrialfibrillation (AF) and is recommended.
Circulation, Volume 150, Issue Suppl_1 , Page A4142376-A4142376, November 12, 2024. Limited data indicate an elevated risk of atrialfibrillation (AF) after neoadjuvant chemoradiation in esophageal cancer however the role of AF as an independent predictor of outcomes post-esophagectomy remains under-studied.
Stroke, Volume 55, Issue Suppl_1 , Page ATP252-ATP252, February 1, 2024. Objective:Forward head posturing (FHP) has been associated with chronic anatomic vertebral artery disturbances possibly leading to posterior circulation ischemia. Information on demographics and comorbidities were also collected. degrees compared to 17.7
Circulation, Volume 150, Issue Suppl_1 , Page A4139988-A4139988, November 12, 2024. Background:Ablation is an increasingly preferred treatment for patients with atrialfibrillation (AF), yet the optimal catheter configuration to record electrical activity (electrograms) is undefined.
Circulation, Volume 150, Issue Suppl_1 , Page A4140664-A4140664, November 12, 2024. While studies have linked this genetic mutation to severe cardiac hypertrophy, a connection to persistent atrialfibrillation (AF) is unestablished.
Results will be presented at the American Heart Association/American Stroke Association ( AHA / ASA ) International Stroke Conference ( ISC ) 2024 in Phoenix. Circulation vol. For more information: www.medtronic.com References: [i] Tsao, Connie W et al. 147,8 (2023): e93-e621. doi:10.1161/CIR.0000000000001123
Circulation, Volume 150, Issue Suppl_1 , Page A4137989-A4137989, November 12, 2024. Background:A bimodal P wave in lead II reflects left atrial remodeling and is described as a notched P wave. A notched P wave is also known to predict atrialfibrillation (AF) after catheter ablation.
Circulation: Cardiovascular Imaging, Volume 17, Issue 1 , Page e015969, January 1, 2024. BACKGROUND:Postoperative atrialfibrillation (POAF) is a common complication after cardiac surgery being associated with poorer outcomes.
Circulation, Volume 150, Issue Suppl_1 , Page A4147213-A4147213, November 12, 2024. Introduction:Stroke prevention with anticoagulation is an important aspect of atrialfibrillation (AF) management. Diabetes is accepted as a risk factor for stroke in AF, but the threshold at which stroke risk increases is uncertain.
Circulation, Volume 150, Issue Suppl_1 , Page A4143007-A4143007, November 12, 2024. This study focuses on the correlation between FAI and the morbidity of new-onset atrialfibrillation (NOAF) in MINOCA patients.Methods:This study was a single-center, observational clinical cohort study.
Circulation, Volume 150, Issue Suppl_1 , Page A4142210-A4142210, November 12, 2024. The importance of transesophageal echocardiogram (TEE) to exclude left atrial (LA) and left atrial appendage (LAA) thrombus prior to cardioversion for atrialfibrillation (AF) has been debated in patients who are anticoagulated prior to cardioversion.
milla1cf Thu, 06/06/2024 - 21:44 June 6, 2024 — A new, robotic approach to heart bypass surgery is now being offered to patients at University Hospitals ( UH ) with great success. Implementing a robotics program is just another proof point for UH Harrington Heart & Vascular Institute as a national leader in MIDCAB.
This study aims to visualize the developmental trajectory of PSC-CM research over the past 18 years to identify the emerging research frontiers and challenges.MethodsThe literature on PSC-CMs from 2007 to 2024 was retrieved from the Web of Science and PubMed databases. Wu standing out as the most productive and highly cited scholar.
Circulation, Volume 150, Issue Suppl_1 , Page A4142494-A4142494, November 12, 2024. Background:Atrial fibrillation (AF) is the most common type of cardiac arrhythmia, affecting over 59 million individuals worldwide.
trillion by 2050, according to two presidential advisories published in the AHA journal Circulation. christine.book Tue, 06/18/2024 - 11:22 June 18, 2024 — At least 6 in 10 adults in an older, more diverse U.S. The landscape of cardiovascular disease in the U.S.
Methods We systematically searched PubMed, EMbase, The Cochrane Library and ClinicalTrials.gov for randomized clinical trials (published by 14 January 2024) comparing del Nido cardioplegia to cold blood cardioplegia in adult. Our main endpoints were myocardial injury markers and clinical outcomes.
Circulation, Volume 150, Issue Suppl_1 , Page A4122350-A4122350, November 12, 2024. of senior patients with age-related diseases such as hypertension, dyslipidemia and atrialfibrillation had PVTs, as estimated by cardiac computed tomography (CT) and transesophageal echocardiography (TEE). In 2022, we reported that 98.6%
BackgroundThis study aimed to assess the scientific results and activities of premature beats research from a global perspective.MethodsPublications related to premature beats published between 2003 and 2024 were identified and selected from the Web of Science core collection. The most cited references come from the journal named Circulation.
Circulation, Volume 150, Issue Suppl_1 , Page A4142314-A4142314, November 12, 2024. On pooled analysis, presence of atrialfibrillation/flutter [OR 1.54, 95% CI 1.22-1.95, Background:Reducing heart failure (HF) readmission rates remains a global healthcare priority. 0.72, p <0.01] (1C).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
115 
Let's personalize your content